Trial Profile
Effect of sapropterin on variations of blood phenylalanine and tyrosine over 24 hours and from day to day in children with phenylketonuria
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Sapropterin (Primary)
- Indications Phenylketonuria
- Focus Therapeutic Use
- 09 Nov 2016 Planned End Date changed to 21 Mar 2016.
- 09 Nov 2016 New trial record